Investment

What are the Current Investment Trends in the Pharmaceutical Industry, and How are They Influencing the Sector’s Direction?

Pharma's Almanac

Supply Chain

Rethinking the Pharma/Biopharma Supply Chain to Maximize Resilience

Tim Tyson; Jesse McCool, Ph.D.; Russell Harris; Yongkwan Ma

TriRx Pharmaceutical Services

Expansion

Vetter looks ahead to further expansions to meet supply chain demand

Vetter Pharma International GmbH

Business Leadership

Wheeler Bio Appoints Marc Helouin as Chief Quality and Regulatory Officer

Wheeler Bio

Brand Relaunch

Techceuticals Announces Relaunch with an Expanded Focus on the Pharmaceutical Industry

Techceuticals

Vantage Nutrition LLC Acquires ComboCap Inc

Vantage Nutrition

mRNA Manufacturing

Investing in the Future of mRNA Manufacturing

Esther Yoo, Ph.D.

Samsung Biologics

Investment

Orgenesis Secures up to USD 50 Million Subsidiary-Level Investment from Metalmark Capital to Accelerate Growth of Point-of-Care Services

Orgenesis

Warehouse Storage

New Fully Automated Vetter Warehouse Expands Storage and Boosts Logistical Infrastructure

Vetter Pharma International GmbH

Series A Funding

Wheeler Bio Announces Initial Closing of Series A Round Supporting New Biologics Drug Substance GMP Expansion In Oklahoma

Wheeler Bio

Business Leadership

Olon Announces the Appointment of Roberta Pachera as Vice President of CDMO Small Molecules and Global Key Account Division

Olon

Manufacturing Investment

MilliporeSigma Announces Investment of More Than € 130 Million to Strengthen Manufacturing Capabilities in Molsheim, France

MilliporeSigma

Acquisition and Rebranding

Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio

AcuraBio

Cosmeceuticals

Cosmeceuticals Are Here. When Will Regulations Catch Up?

Ameena Pathan

That's Nice LLC

New Project Funding

NIIMBL Announces $15.8M to Fund 14 New Biopharmaceutical Manufacturing Projects

NIIMBL

M&A

Sartorius to Acquire Albumedix, Creating a Powerhouse for Innovative Advanced Therapy Solutions

Albumedix

New Division

Olon Presents Olon Biotech, A New Division Operating by Biotechnological Processes

Olon

Column: M&A

Who's Left to Acquire in CDMO Biomanufacturing? A Select Few.

Nigel Walker

Nice Insight

Column: Investment

IPOs Have Not Recovered In 2022. When Will Biotech Bounce Back?

Danielle Alvarez

Pharma's Almanac

mRNA Manufacturing

Vernal Biosciences Raises $21 Million to Accelerate mRNA Manufacturing Growth

Vernal Biosciences